Research Article
High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform
Table 3
Overall changes in parameters after HIFU focal therapy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SD, standard deviation; PSA, prostatic specific antigen; PHI, prostate health index; IPSS, International Prostate Symptom Score; QoL, quality of life; OABSS, overactive bladder symptom score; IIEF-5, International Index of Erectile Function; SF-12, 12-item short form survey; EPIC-25, expanded prostate cancer index composite; LUTS, lower urinary tract symptoms; Qmax, maximal voiding velocity; PVRU, postvoid residual urine. #Comparison of 3-month data against the baseline value. Comparison of 6-month data against the baseline value. |